Vascular Graft Market

Global Vascular Graft Market Size

The size of the global vascular graft market was worth USD 2 billion in 2025. The global market is anticipated to grow at a CAGR of 7.4% from 2026 to 2034 and be worth USD 3.80 billion by 2034 from USD 2.15 billion in 2026.

Vascular grafts are used for hemodialysis vascular access and endovascular aneurysm & thoracic aneurysm repair. A vascular graft is a surgical process to redirect blood from an area of normal blood flow to another relatively normal area. Various vascular grafts are based on the indication and raw material used for the graft to suit the host tissue.

MARKET DRIVERS

The growing incidence of end-stage renal disease and vascular occlusions is majorly driving the vascular graft market growth.

Across the globe, around 2 million people are suffering from ESRD, as per the University of California. In regions such as the US, Taiwan, Belgium, Mexico, and Japan, nearly 650,000 people suffer from ESRD. So, there is a high prevalence of ESRD. Growing disposable income in urban areas is also greatly influencing the growth rate of the market. There is an increase in the geriatric population worldwide, creating a positive impact on the market. The prevalence of a sedentary lifestyle, in which there are smoking and drinking, has boosted the market growth. The rise in diabetes cases has also increased the number of patients requiring the vascular shaft, contributing more to the growth rate. Cardiovascular diseases are a significant cause of death worldwide, and this vascular graft is used to treat such diseases.

The vascular graft market is providing opportunities for emerging markets. Emerging markets like Singapore, China, Japan, and Australia are presenting significant opportunities for players to operate in the vascular graft market. The market is expected to experience substantial growth in the forthcoming years due to lenient regulatory policies and the increasing burden of aneurysms. In addition to expanding geographic reach, significant players are prompting an emerging market. These are opportunities provided for the vascular graft market.

MARKET RESTRAINTS

The major restraint in the vascular graft market is the failure of the product and recalls. For many years, products offered by companies due to malfunctions or other issues. End-user perception of the safety of grafts can be hurt by market development. It can affect the adoption of the treatment process, which is also hindering the market's growth rate. The other significant restraint of the market is to make the vascular graft procedure less costly and more affordable to people. The low reimbursements for people have also hindered market growth and are expected to impact the future negatively. The development of healthcare facilities is not at the same level everywhere, and the procedure requires high-quality facilities, thus negatively impacting the market growth. Complications associated with prosthetic grafts are also a major restraint to the market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Insights

Based on the product, the Endovascular stent grafts segment accounted for the largest share owing to the rise in the adoption of endovascular aneurysm repair surgeries, the increment of preference for minimally invasive surgical processes over open surgeries, and the growth of the geriatric population.

By Raw Material Insights

Based on raw material, polyester-based grafts dominate the market due to the easy availability of raw material, high tensile strength, and durability. The leadership of this segment is attributed to the growth in the easy availability of raw materials, high tensile strength, and more durability than other material grafts. In addition, the increasing cases and rising awareness have also boosted market growth.

Polytetrafluoroethane is expected to grow fastest among all other segments during the forecast period. PTFE is fabricated with a technically advanced architecture that minimizes blood loss and provides maximum protection against delamination. The PTFE material is also used for peripheral bypasses and extra anatomical procedures. In addition, the increase in the number of cases of cardiovascular diseases will ensure the growth of the market.

By End User Insights

The hospital segment is expected to grow at the highest growth rate during the forecast period based on the end-user. The availability of better-quality healthcare infrastructure and facilities has positively impacted this sub-segment. In addition, the rise of minimally invasive procedures at hospitals has also accelerated market growth, and the favorable reimbursement scenario in most developed countries has allowed more people to undertake these surgeries.

Ambulatory surgical centers will also grow reasonably in the future, mainly due to rising CVD cases and advancements in healthcare facilities.

By Application Insights

Based on the application, the cardiac aneurysms segment led the market in 2024 and is expected to grow at a reasonable rate due to factors such as the high prevalence of high blood pressure and the advent of advanced tissue-engineered grafts for pediatric congenital heart surgeries. In addition, the development in healthcare facilities will help this sub-segment to grow.

 The increasing geriatric population and unhealthy lifestyle habits, such as alcohol consumption and smoking, are anticipated to contribute to the rising growth rate during the forecast period.

REGIONAL ANALYSIS

North America Vascular Graft Market Analysis

Geographically, the North American vascular graft treatment market is expected to have the largest market share due to factors like the increasing geriatric population suffering from cardiovascular diseases, diabetes, and end-stage renal diseases. Expecting that North America will maintain its position as it has a prevalence of diabetes, cardiovascular diseases, and chronic kidney diseases. Moreover, advanced technology is also available, and reimbursement coverage is a driving factor in the vascular graft market. The increase in diabetes cases, cardiovascular diseases, and kidney problems have boosted this region's growth.

Europe Vascular Graft Market Analysis

The European vascular graft treatment market is expected to grow rapidly during the forecast period. Europe is also attributing the highest compound annual growth rate as it increases the number of biomaterials research projects. A partnership was made by the European Union with a medical organization to provide funds. An increase in incidences of cardiovascular diseases and the growth of accepting prosthetic graft implantation in the Europe region. The main reason for this growth is the increase in the geriatric population, healthcare facilities, and better healthcare quality. The rising initiatives will accelerate the market further.

Asia-Pacific Vascular Graft Market Analysis

During the forecast period, the Asia-Pacific vascular graft treatment market is the second-largest regional market in the vascular graft market, with a compound annual growth rate of 8.1%. Improvement of healthcare infrastructure and incidences of cardiovascular diseases and diabetes are the attributing factors in the Asia-Pacific region. Moreover, a rapid increase in epidemiological transition resulted in many premature deaths, expected as a booster demand for minimally invasive grafting procedures during the forecast period. In addition, the implementation of extensive R&D for new product development is due to a rise in heart failure cases. 

KEY MARKET PLAYERS

Some of the key companies playing a dominant role in the global vascular graft market profiled in this report are

• Endologix Inc.
• LeMaitre Vascular, Inc.
• MAQUET Holding B.V.
• B. Braun Melsungen AG & Co. KG
• Medtronic plc
• C. R. Bard, Inc.
• Cardinal Health Inc.
• Cook Medical Inc.
• Terumo Corporation
• W. L. Gore & Associates, Inc.

GLOBAL VASCULAR GRAFT MARKET NEWS

• In October 2017, Medtronic Endurant II/IIs, an FDA-approved product, was received by Medtronic to use with the Heli-FX EndoAnchor system. It is a thoracic stent graft system.
• In April 2017, an agreement was signed by Endologix Inc. with Deerfield Management to allot funds worth USD 170 million. It is a leading healthcare investment organization.
• In January 2017, for AFX and AFX 2 Endovascular AAA system, reinstatement of the CE Mark was received by Endologix.

MARKET SEGMENTATION

This research report on the global vascular graft market has been segmented and sub-segmented into the following categories.

By Product

• Peripheral Vascular Graft  
• Endovascular Aneurysm Repair Stent Grafts
  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic Aneurysm (TAA)
• Hemodialysis Access Graft

By Raw Material

• Biosynthetic      
• Polyester 
• Polyurethane (PU)        
• Polytetrafluoroethylene (PTFE)

By End User

• Ambulatory Surgical Centers      
• Hospitals

By Application

• Coronary Artery Disease  
• Aneurysm        
• Vascular Occlusion        
• Renal Failure      
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa